InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.08
(
-0.06%
)
Bitcoin
63,991.79
(
-0.01%
)
Post# of 14671
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

scruffy89

Send PM Follow Ignore
Followers 4
Posts 241
Boards Moderated 0
Alias Born 02/21/2002

scruffy89

Re: None

Wednesday, 11/20/2002 10:32:20 AM

Wednesday, November 20, 2002 10:32:20 AM

Post# of 14671
News......

IBCI Enters into Second Phase of Testing with Global Food and Beverage Company
After Initial Test Results Prove Effective

ATLANTA, Nov. 20 /PRNewswire-FirstCall/ -- International BioChemical
Industries, Inc. (OTC Bulletin Board: IBCL) is excited to announce today that
it has recently moved into the second round of testing in a cooperative effort
with a global company after initial testing proves effective. Ms. Deirdre
Baker, IBCI's General Manager stated, "We have now entered into a new phase of
expanding the use of our technology in the food and beverage industry, in
which the company has spent five years in development and multiple years in
patent protection as announced on November 19, 2002. As a result of this
continuing effort, new technologies and new applications for IBCI's
antimicrobial agents may be developed in the marketplace. We are confident
from the initial test results that this second phase should prove our
technology successful."

About International BioChemical Industries, Inc.:
International BioChemical Industries, Inc. is a Norcross, Georgia-based
emerging growth company focused in biotechnology and antimicrobial products.
Its core business is committed to the discovery, development, marketing and
sale of surface-modifying antimicrobial and biostatic products. The company's
antimicrobial technology is a revolutionary alternative to conventional
sanitizers, disinfectants, bleaches, biocides or preservatives primarily
because it kills bacteria, including HIV, on contact and can remain active for
extended time periods. To date BioShield has received three US patents and
six EPA registrations, including the first U.S. germ killer and disinfectant
against Salmonella cholerasuis, Staphylococcus aureus and other
microorganisms. The company has developed several alliances in different
industries, such as healthcare, textiles and storm water.

Further information on IBCI and its line of products can be found by
visiting the firm's web site at http://www.bioshield.com, or by calling
Deirdre Baker at +1-770-925-3653.

Safe Harbor/Forward-looking Statements: .......... etc.


scruffy


Drink Maine Beer
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up